| __timestamp | ADMA Biologics, Inc. | Alpine Immune Sciences, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 2287709 |
| Thursday, January 1, 2015 | 6745968 | 6844000 |
| Friday, January 1, 2016 | 8494742 | 8586000 |
| Sunday, January 1, 2017 | 18092835 | 6079000 |
| Monday, January 1, 2018 | 22502922 | 8362000 |
| Tuesday, January 1, 2019 | 25910757 | 9467000 |
| Wednesday, January 1, 2020 | 35050817 | 10899000 |
| Friday, January 1, 2021 | 42896889 | 14560000 |
| Saturday, January 1, 2022 | 52458024 | 17968000 |
| Sunday, January 1, 2023 | 59020000 | 22222000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing expenses is crucial for sustained growth. Over the past decade, ADMA Biologics, Inc. and Alpine Immune Sciences, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ADMA Biologics saw a staggering 1,124% increase in SG&A expenses, reflecting its aggressive expansion and operational scaling. In contrast, Alpine Immune Sciences experienced a more moderate 872% rise, indicating a steady yet cautious growth strategy.
By 2023, ADMA Biologics' SG&A expenses were approximately 2.7 times higher than those of Alpine Immune Sciences, highlighting their differing approaches to market penetration and resource allocation. This divergence in financial strategy underscores the varied paths companies can take in the biotech sector, each with its own set of challenges and opportunities.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Summit Therapeutics Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Apellis Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and MannKind Corporation
Cost Management Insights: SG&A Expenses for ADMA Biologics, Inc. and Rhythm Pharmaceuticals, Inc.
ADMA Biologics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
ADMA Biologics, Inc. vs Ligand Pharmaceuticals Incorporated: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing ADMA Biologics, Inc. and BioCryst Pharmaceuticals, Inc.